港股异动 | 君实生物(01877)再涨超3% 关注AACR大会JS207和JS212数据读出

智通财经
Yesterday

智通财经APP获悉,君实生物(01877)再涨超3%,截至发稿,涨2.83%,报28.32港元,成交额1.08亿港元。

消息面上,全球肿瘤学盛会美国癌症研究协会(AACR)2026年年会将于4月17日至22日在美国圣地亚哥会议中心举行。太平洋证券指出,君实生物JS207(PD-1/VEGF)于2026 AACR大会上披露1LCRC(联合化疗)、1LHCC(联合CTLA4单抗)临床数据,有望年内进入关键注册临床;JS212(EGFR/HER3ADC)于AACR上披露早期数据,计划年底启动关键注册临床。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10